Oloduet Tablet 20/5 mg

Adult dose

Olmesartan Medoxomil: The recommended initial dosage for adults is 10 mg once daily, regardless of meals. If blood pressure is not adequately controlled, the dose can be increased to 20 mg once daily, and if needed, it can be further increased to a maximum of 40 mg. Elderly and mildly impaired liver function patients do not require dose adjustments, while patients with moderate liver impairment are recommended to start with 10 mg once daily and may increase to a maximum of 20 mg. Renal impairment.

Child dose

The safety and efficacy in children under 18 years have not been established.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be used in women who are allergic to any ingredients, pregnant or nursing, or in patients with severely compromised renal function. Administration should also be avoided in patients with severely impaired renal or liver function, biliary obstruction, muscle diseases, or when used in combination with certain medications. Careful monitoring is required for patients with significantly low blood pressure or reduced blood volume due to the risk of hypotension. This medication may increase serum potassium levels, posing a risk of hyperkalemia, particularly in patients with kidney disease or heart failure, requiring regular potassium level monitoring. Muscle pain, muscle weakness, and rarely severe muscle damage (rhabdomyolysis) may occur, and if any muscle-related symptoms appear, medical assistance must be sought immediately. Liver function abnormalities may occur, so regular liver function tests are recommended before and during treatment. Due to potential side effects such as dizziness, caution is advised while driving or operating dangerous machinery. The risk of side effects may increase when used in combination with certain medications, so if any other medications are being taken, the healthcare provider must be informed. The safety and efficacy of this drug in children and adolescents under 18 years have not been established, so its use is not recommended. In elderly patients, dosage adjustments and careful monitoring are advised due to potential increased drug concentration. In case of overdose, symptoms such as hypotension and palpitations may occur, and appropriate treatment should be received if necessary. This medication should be stored out of the reach of children and should not be transferred to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme malaise, sudden severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, reduced urine output.

Mild side effects

• Headache
• dizziness
• decreased perception
• drowsiness
• gastroesophageal reflux
• constipation
• dental caries
• dyspepsia
• gastric ulcer
• gastritis

This medication should be stored in a tightly sealed container to protect it from air and moisture, and the storage temperature should be maintained between 1°C to 30°C. This will ensure the medication's effectiveness is safely preserved.

Appearance

White or off-white round film-coated tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu*3]